{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:39:20Z","timestamp":1790800760527,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T00:00:00Z","timestamp":1490572800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical foundation","doi-asserted-by":"publisher","award":["320.6750.16023"],"award-info":[{"award-number":["320.6750.16023"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s11255-017-1574-2","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T05:17:51Z","timestamp":1490591871000},"page":"1233-1241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy"],"prefix":"10.1007","volume":"49","author":[{"given":"Ruitong","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,27]]},"reference":[{"key":"1574_CR1","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJMra020109","volume":"347","author":"JV Donadio","year":"2002","unstructured":"Donadio JV, Grande JP (2002) IgA nephropathy. N Engl J Med 347:738\u2013748","journal-title":"N Engl J Med"},{"key":"1574_CR2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000409751","volume":"40","author":"D Droz","year":"1984","unstructured":"Droz D, Kramar A, Nawar T, Noel LH (1984) Primary IgA nephropathy: prognostic factors. Contrib Nephrol 40:202\u2013207","journal-title":"Contrib Nephrol"},{"key":"1574_CR3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/ki.1986.33","volume":"29","author":"JR Beukhof","year":"1986","unstructured":"Beukhof JR, Kardaun O, Schaafsma W, Poortema K, Donker AJ, Hoedemaeker PJ, van der Hem GK (1986) Toward individual prognosis of IgA nephropathy. Kidney Int 29:549\u2013556","journal-title":"Kidney Int"},{"key":"1574_CR4","first-page":"346","volume":"7","author":"M Velo","year":"1987","unstructured":"Velo M, Lozano L, Egido J, Gutierrez-Millet V, Hernando L (1987) Natural history of IgA nephropathy in patients followed-up for more than ten years in Spain. Semin Nephrol 7:346\u2013350","journal-title":"Semin Nephrol"},{"key":"1574_CR5","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/01.ASN.0000068460.37369.DC","volume":"14","author":"M Praga","year":"2003","unstructured":"Praga M, Gutierrez E, Gonzalez E, Morales E, Hernandez E (2003) Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. J Am Soc Nephrol 14:1578\u20131583","journal-title":"J Am Soc Nephrol"},{"key":"1574_CR6","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1681\/ASN.2011111112","volume":"23","author":"J Lv","year":"2012","unstructured":"Lv J, Xu D, Perkovic V, Ma X, Johnson DW, Woodward M, Levin A, Zhang H, Wang H, Group TS (2012) Corticosteroid therapy in IgA nephropathy. J Am Soc Nephrol 23:1108\u20131116","journal-title":"J Am Soc Nephrol"},{"key":"1574_CR7","first-page":"184","volume":"35","author":"KT Woo","year":"1991","unstructured":"Woo KT, Lee GS (1991) The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin. Clin Nephrol 35:184","journal-title":"Clin Nephrol"},{"key":"1574_CR8","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1523-1755.2004.00588.x","volume":"65","author":"BD Maes","year":"2004","unstructured":"Maes BD, Oyen R, Claes K, Evenepoel P, Kuypers D, Vanwalleghem J, Van Damme B, Vanrenterghem YF (2004) Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study. Kidney Int 65:1842\u20131849","journal-title":"Kidney Int"},{"key":"1574_CR9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12016-010-8232-0","volume":"41","author":"HH Yu","year":"2011","unstructured":"Yu HH, Chu KH, Yang YH, Lee JH, Wang LC, Lin YT, Chiang BL (2011) Genetics and immunopathogenesis of IgA nephropathy. Clin Rev Allergy Immunol 41:198\u2013213","journal-title":"Clin Rev Allergy Immunol"},{"key":"1574_CR10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nature06033","volume":"448","author":"H Tezuka","year":"2007","unstructured":"Tezuka H, Abe Y, Iwata M, Takeuchi H, Ishikawa H, Matsushita M, Shiohara T, Akira S, Ohteki T (2007) Regulation of IgA production by naturally occurring TNF\/iNOS-producing dendritic cells. Nature 448:929\u2013933","journal-title":"Nature"},{"key":"1574_CR11","doi-asserted-by":"crossref","first-page":"819646","DOI":"10.1155\/2011\/819646","volume":"2011","author":"T Kajiyama","year":"2011","unstructured":"Kajiyama T, Suzuki Y, Kihara M, Suzuki H, Horikoshi S, Tomino Y (2011) Different pathological roles of toll-like receptor 9 on mucosal B cells and dendritic cells in murine IgA nephropathy. Clin Dev Immunol 2011:819646","journal-title":"Clin Dev Immunol"},{"key":"1574_CR12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/ndt\/gfm595","volume":"23","author":"JW Eijgenraam","year":"2008","unstructured":"Eijgenraam JW, Reinartz SM, Kamerling SW, van Ham VJ, Zuidwijk K, van Drunen CM, Daha MR, Fokkens WJ, van Kooten C (2008) Immuno-histological analysis of dendritic cells in nasal biopsies of IgA nephropathy patients. Nephrol Dial Transplant 23:612\u2013620","journal-title":"Nephrol Dial Transplant"},{"key":"1574_CR13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2249.2009.04045.x","volume":"159","author":"R Coppo","year":"2010","unstructured":"Coppo R, Camilla R, Amore A, Peruzzi L, Dapra V, Loiacono E, Vatrano S, Rollino C, Sepe V, Rampino T, Dal Canton A (2010) Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy. Clin Exp Immunol 159:73\u201381","journal-title":"Clin Exp Immunol"},{"key":"1574_CR14","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1681\/ASN.2007121311","volume":"19","author":"H Suzuki","year":"2008","unstructured":"Suzuki H, Suzuki Y, Narita I, Aizawa M, Kihara M, Yamanaka T, Kanou T, Tsukaguchi H, Novak J, Horikoshi S, Tomino Y (2008) Toll-like receptor 9 affects severity of IgA nephropathy. J Am Soc Nephrol 19:2384\u20132395","journal-title":"J Am Soc Nephrol"},{"key":"1574_CR15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-immunol-030409-101314","volume":"28","author":"S Fagarasan","year":"2010","unstructured":"Fagarasan S, Kawamoto S, Kanagawa O, Suzuki K (2010) Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu Rev Immunol 28:243\u2013273","journal-title":"Annu Rev Immunol"},{"key":"1574_CR16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.mehy.2003.11.002","volume":"62","author":"EN Wardle","year":"2004","unstructured":"Wardle EN (2004) Is IgA nephropathy induced by hyperproduction of interferon-alpha? Med Hypotheses 62:625\u2013628","journal-title":"Med Hypotheses"},{"key":"1574_CR17","first-page":"40","volume":"72","author":"KN Lai","year":"2011","unstructured":"Lai KN, Tang SC, Leung JC (2011) Recent advances in IgA nephropathy\u2014the glomerulopodocytic-tubular communication. Adv Otorhinolaryngol 72:40\u201344","journal-title":"Adv Otorhinolaryngol"},{"key":"1574_CR18","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1186\/ar3895","volume":"14","author":"K Sacre","year":"2012","unstructured":"Sacre K, Criswell LA, McCune JM (2012) Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Res Ther 14:R155","journal-title":"Arthritis Res Ther"},{"key":"1574_CR19","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood-2011-01-329060","volume":"118","author":"S Piconi","year":"2011","unstructured":"Piconi S, Parisotto S, Rizzardini G, Passerini S, Terzi R, Argenteri B, Meraviglia P, Capetti A, Biasin M, Trabattoni D, Clerici M (2011) Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders. Blood 118:3263\u20133272","journal-title":"Blood"},{"key":"1574_CR20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1191\/0961203306lu2313oa","volume":"15","author":"N Kasitanon","year":"2006","unstructured":"Kasitanon N, Fine DM, Haas M, Magder LS, Petri M (2006) Hydroxychloroquine use predicts complete renal remission within 12\u00a0months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis. Lupus 15:366\u2013370","journal-title":"Lupus"},{"key":"1574_CR21","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/art.24538","volume":"61","author":"GJ Pons-Estel","year":"2009","unstructured":"Pons-Estel GJ, Alarcon GS, McGwin G Jr, Danila MI, Zhang J, Bastian HM, Reveille JD, Vila LM, Lumina Study G (2009) Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. Arthritis Rheum 61:830\u2013839","journal-title":"Arthritis Rheum"},{"key":"1574_CR22","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0046-8177(82)80221-9","volume":"13","author":"SM Lee","year":"1982","unstructured":"Lee SM, Rao VM, Franklin WA, Schiffer MS, Aronson AJ, Spargo BH, Katz AI (1982) IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol 13:314\u2013322","journal-title":"Hum Pathol"},{"key":"1574_CR23","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.2009.243","volume":"76","author":"DC Cattran","year":"2009","unstructured":"Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D\u2019Agati V, D\u2019Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534\u2013545","journal-title":"Kidney Int"},{"key":"1574_CR24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1523-1755.2005.67107.x","volume":"67","author":"J Novak","year":"2005","unstructured":"Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J (2005) IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 67:504\u2013513","journal-title":"Kidney Int"},{"key":"1574_CR25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1365-2249.2004.02408.x","volume":"136","author":"Y Wang","year":"2004","unstructured":"Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY (2004) Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Clin Exp Immunol 136:168\u2013175","journal-title":"Clin Exp Immunol"},{"key":"1574_CR26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1471-4914(02)02405-X","volume":"8","author":"RC Monteiro","year":"2002","unstructured":"Monteiro RC, Moura IC, Launay P, Tsuge T, Haddad E, Benhamou M, Cooper MD, Arcos-Fajardo M (2002) Pathogenic significance of IgA receptor interactions in IgA nephropathy. Trends Mol Med 8:464\u2013468","journal-title":"Trends Mol Med"},{"key":"1574_CR27","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaci.2010.09.026","volume":"126","author":"I Puga","year":"2010","unstructured":"Puga I, Cols M, Cerutti A (2010) Innate signals in mucosal immunoglobulin class switching. J Allergy Clin Immunol 126:889\u2013895 quiz 896\u20137","journal-title":"J Allergy Clin Immunol"},{"key":"1574_CR28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cellimm.2006.08.002","volume":"241","author":"DD McCarthy","year":"2006","unstructured":"McCarthy DD, Chiu S, Gao Y, Summers-deLuca LE, Gommerman JL (2006) BAFF induces a hyper-IgA syndrome in the intestinal lamina propria concomitant with IgA deposition in the kidney independent of LIGHT. Cell Immunol 241:85\u201394","journal-title":"Cell Immunol"},{"key":"1574_CR29","first-page":"803","volume":"20","author":"K Sperber","year":"1993","unstructured":"Sperber K, Quraishi H, Kalb TH, Panja A, Stecher V, Mayer L (1993) Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells. J Rheumatol 20:803\u2013808","journal-title":"J Rheumatol"},{"key":"1574_CR30","first-page":"R1058","volume":"274","author":"I Karres","year":"1998","unstructured":"Karres I, Kremer JP, Dietl I, Steckholzer U, Jochum M, Ertel W (1998) Chloroquine inhibits proinflammatory cytokine release into human whole blood. Am J Physiol 274:R1058\u2013R1064","journal-title":"Am J Physiol"},{"key":"1574_CR31","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature04641","volume":"440","author":"K Hoshino","year":"2006","unstructured":"Hoshino K, Sugiyama T, Matsumoto M, Tanaka T, Saito M, Hemmi H, Ohara O, Akira S, Kaisho T (2006) IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature 440:949\u2013953","journal-title":"Nature"},{"key":"1574_CR32","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/1529-0131(200104)44:4<856::AID-ANR142>3.0.CO;2-A","volume":"44","author":"C Scheinecker","year":"2001","unstructured":"Scheinecker C, Zwolfer B, Koller M, Manner G, Smolen JS (2001) Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies. Arthritis Rheum 44:856\u2013865","journal-title":"Arthritis Rheum"},{"key":"1574_CR33","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1002\/art.11225","volume":"48","author":"S Blomberg","year":"2003","unstructured":"Blomberg S, Eloranta ML, Magnusson M, Alm GV, Ronnblom L (2003) Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum 48:2524\u20132532","journal-title":"Arthritis Rheum"},{"key":"1574_CR34","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar2382","volume":"10","author":"SK Kwok","year":"2008","unstructured":"Kwok SK, Lee JY, Park SH, Cho ML, Min SY, Park SH, Kim HY, Cho YG (2008) Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus. Arthritis Res Ther 10:R29","journal-title":"Arthritis Res Ther"},{"key":"1574_CR35","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","volume":"284","author":"FP Siegal","year":"1999","unstructured":"Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ (1999) The nature of the principal type 1 interferon-producing cells in human blood. Science 284:1835\u20131837","journal-title":"Science"},{"key":"1574_CR36","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/ki.2014.63","volume":"86","author":"R Coppo","year":"2014","unstructured":"Coppo R, Troyanov S, Bellur S, Cattran D, Cook HT, Feehally J, Roberts IS, Morando L, Camilla R, Tesar V, Lunberg S, Gesualdo L, Emma F, Rollino C, Amore A, Praga M, Feriozzi S, Segoloni G, Pani A, Cancarini G, Durlik M, Moggia E, Mazzucco G, Giannakakis C, Honsova E, Sundelin BB, Di Palma AM, Ferrario F, Gutierrez E, Asunis AM, Barratt J, Tardanico R, Perkowska-Ptasinska A (2014) Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int 86:828\u2013836","journal-title":"Kidney Int"},{"key":"1574_CR37","first-page":"503","volume":"18","author":"R Coppo","year":"2005","unstructured":"Coppo R, D\u2019Amico G (2005) Factors predicting progression of IgA nephropathies. J Nephrol 18:503\u2013512","journal-title":"J Nephrol"},{"key":"1574_CR38","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/ndt\/gfr527","volume":"27","author":"W Le","year":"2012","unstructured":"Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z (2012) Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant 27:1479\u20131485","journal-title":"Nephrol Dial Transplant"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-017-1574-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1574-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1574-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T04:15:17Z","timestamp":1497413717000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-017-1574-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,27]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["1574"],"URL":"https:\/\/doi.org\/10.1007\/s11255-017-1574-2","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,27]]}}}